SIGN IN
|
SIGN UP
ISSN 0973 - 9289
HOME
(current)
TOPICS
ASK A DOCTOR
GRAND ROUNDS
Question of the week
BLOGS
SUBMIT
CONFERENCE
VIDEOS
SUBMIT ARTICLE
You must sign in first to submit the article.
Click here to
Sign In
Article Title :
Please enter the title.
Special Chars Other than , . - ( ) " Are Not Allowed (Min 2 and Max 100 chars).
Name of Corresponding Author :
Please enter the name.
Special Chars Are Not Allowed (Min 2 and Max 100 chars).
+ Add Co-Author
Name of Corresponding Author :
Please enter the department
Special Chars Other than , . - ( ) " Are Not Allowed (Min 2 and Max 100 chars).
E-mail :
Please enter the Email ID.
Enter the valid Email ID.
Correspondence Address :
Please enter the address.
Special Chars Other than , . - ( ) / \ # Are Not Allowed (Min 2 and Max 100 chars).
Submit Abstarct :
Please enter the abstract.
Enter valid abstract with min 5 and max 8000 chars allowed.
Attach manuscript
*
:
Manuscript Type: .txt/.doc/.docx
Please Upload ManuScript.
Attach image if any :
Image Type: .jpg/.gif
Conflict of Interest:
Yes
No
If yes, please state:
Please enter the conflict of interest.
Enter valid conflict of interest with min 5 and max 1500 chars allowed.
Funding:
Yes
No
If yes, please enter funding institute name:
Please enter the funding.
Enter valid funding with min 5 and max 1500 chars allowed.
Disclosures:
Yes
No
If yes, please state:
Please enter the disclosure.
Enter valid disclosure with min 5 and max 1500 chars allowed.
Select Category:
--Select Article Type Category--
Brief Report
Case Reports
Diagnostic Dilemma
Grand Rounds
Image Gallery
Original Article
Research Letter
Review Articles
Viewers Choice
Select type of article.
Click here to see the Instructions for the Author.
(
I Agree
)
*Required
Click here to see the Copyright declaration for the Author.
(
I Agree
)
*Required
Click here to see the Editorial Policies for the Author.
(
I Agree
)
*Required
Click here to download Patient Consent Form
Verification Code :
=
*
Enter Only Numerics
HIV GRAND ROUNDS
A 32 years old HIV infected pregnant female (G2P2L1) presented at 36 weeks of pregnancy for deciding neonatal antiretroviral (ARV) prophylaxis. Her HIV viral load at 34 weeks of gestation was undetectable and she was on antiretroviral therapy (ART) consisting ....
HIV IN CHILDREN APPS